Polycystic disease of the liver

Hepatology

Volumn 40, Issue 4, 2004, Pages 774-782

  Everson, Gregory T ^a   Taylor, Matthew R G ^a   Doctor, R Brian ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATION CHANNEL; EXTRACELLULAR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; GENE PRODUCT; HEPATOCYSTIN; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; POLYCYSTIN 1; POLYCYSTIN 2; PROTEIN; UNCLASSIFIED DRUG;

AD PKD1 GENE; AD PKD2 GENE; AMINO TERMINAL SEQUENCE; ASPIRATION; ASPIRATION CYTOLOGY; AUTOSOMAL DOMINANT DISORDER; CALCIUM TRANSPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYST ASPIRATION; CYST FENESTRATION; DIAGNOSTIC IMAGING; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FENESTRATION; GASTROINTESTINAL ENDOSCOPY; GENE; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GLYCOSYLATION; LAPAROSCOPIC SURGERY; LIVER ANGIOGRAPHY; LIVER CYST; LIVER DISEASE; LIVER FAILURE; LIVER POLYCYSTIC DISEASE; LIVER RESECTION; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PKD1 GENE; PKD2 GENE; POLYCYSTIC LIVER DISEASE GENE; PRIORITY JOURNAL; PRKCSH GENE; PUBERTY; REVIEW; RNA TRANSLATION; SCLEROTHERAPY; SIGNAL TRANSDUCTION;

EID: 4644276506     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.1840400404     Document Type: Review

References (94)

1. Pick GM, Gabow PA. Natural history of autosomal dominant polycystic kidney disease. Ann Rev Med 1994;45:23-29.
2. D'Agata ID, Jonas MM, Perez-Atayde AR, Guay-Woodford LM. Combined cystic disease of the liver and kidney. Semin Liver Dis 1994;14:215-228.
3. Gabow PA, Johnson AM, Kaehny WD, Manco-Johnson ML, Duley IT, Everson GT. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. HEPATOLOGY 1990;11:1033-1037.
4. Harris RA, Gray DW, Britton BJ, Toogood GJ, Morris PJ. Hepatic cystic disease in an adult polycystic kidney disease transplant population. Austral New Zeal J Surg 1996;66:166-168.
5. Everson GT. Hepatic cysts in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1993;22:520-525.
6. Everson G. Hepatic cysts in ADPKD. Mayo Clin Proc 1990;65:1020-1025.
7. Hateboer N, van Dijk MA, Bogdanova M. Comparison of phenotypes of PKD types 1 and 2. European PKD1-PKD2 Study Group. Lancet 1999;353:103-107.
8. Pick GM, Gabow PA. Hereditary and acquired cystic disease of the kidney. Kidney Int 1994;46:951-964.
9. deAlmeida S, deAlmeida E, Peters D, Pinto JR, Tavora I, Lavinha J, et al. ADPKD: evidence for the existence of a third locus in a Portugese family. Hum Genet 1995;96:83-88.
10. Ariza M, Alvarez V, Marin R, Aguado S, Lopez-Larrea C, Alvarez J, et al. A family with a milder form of ADPKD is not linked to PKD1(16p) or PKD2(4q) genes. J Med Genet 1997;96:587-589.
11. Paterson AD, Pei Y. Is there a third gene for ADPKD? Kidney Int 1998;54:1759-1761.
12. Zerres K, Vopel M, Weib H. Cystic kidneys. Genetics, pathologic anatomy, clinical picture and prenatal diagnosis. Hum Genet 1984;68:104-135.
13. Zerres K, Mucher G, Becker J, Steinkamm C, Rudnik-Schoneborn S, Heikkila P. Prenatal diagnosis of ARPKD: molecular genetics, clinical experience and fetal morphology. Am J Med Genet 1998;76:137-144.
14. Grunfeld JP, Albouze G, Jungers P, Landais P, Dana A, Droz D, et al. Liver changes and complications in adult polycystic kidney disease. Adv Nephrol 1985;14:1-20.
15. Chauveau D, Fakhouri F, Grunfeld J-P. Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma. J Am Soc Nephrol 2000;11:1767-1775.
16. Perrone RD, Ruthazer R, Terrin NC. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality. Am J Kidney Dis 2001;38:777-784.
17. Qian Q, Li A, King BF, Kamath PS, Lager DJ, Huston JI, et al. Clinical profile of autosomal dominant polycystic liver disease. HEPATOLOGY 2003;37:164-171.
18. Shrestha R, Mckinley C, Russ P, Scherzinger A, Bonner T, Showalter R, et al. Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. HEPATOLOGY 1997;26:1282-1286.
19. Dalgaard OZ. Bilateral polycystic disease of the kidneys; a follow-up of 284 patients and their families. Dan Med Bull 1957;4:128-133.
20. Reeders ST, Breuning MH, Davies KE, Nicholls RD, Jarman AP, Higgs DR, et al. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 1985;317:542-544.
21. Ward CJ, Turley H, Ong AC, Comley M, Biddolph S, Chetty R, et al. Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc Natl Acad Sci U S A 1996;93:1524-1528.
22. Consortium IP. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 1995;81:289-298.
23. Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 1995;10:151-159.
24. Rossetti S, Strmecki L, Gamble V, Burton S, Sneddon V, Peral B, et al. Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications. Am J Hum Genet 2001;68:46-63.
25. Watnick TJ, Phakdeekitcharoen B, Johnson A, Gandolf M, Wang M, Briefel G, et al. Mutation detection of PKD1 identifies a novel mutation common to three families with aneurysms and/or very-early-onset disease. Am J Hum Genet 1999;65:1561-1571.
26. Rossetti S, Chauveau D, Kubly V, Slezak JM, Saggar-Malik AK, Pei Y, et al. Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 2003;361:2196-2201.
27. Rossetti S, Burton S, Strmecki L, Pond GR, San Millan JL, Zerres K, et al. The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol 2002;13:1230-1237.
28. Gabow P. Autosomal dominant polycystic kidney disease. New Eng J Med 1993;329:332-342.
29. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996;272:1339-1342.
30. Deltas CC. Mutations of the human polycystic kidney disease 2 (PKD2) gene. Hum Mut 2001;18:13-24.
31. Hateboer N, Veldhuisen B, Peters D, Breunning MH, San Millan JL, Bogdanova M, et al. Location of mutations within the PKD2 gene influences clinical outcomes. Kidney Int 2000;57:1444-1451.
32. Qian F, Watnick TJ, Onuchic LF, Germino GG. The molecular basis of focal cyst formation in human ADPKD type I. Cell 1996;87:979-987.
33. Wu G, D'Agati V, Cai Y, Markowitz GS, Park JH, Reynolds DM, et al. Somatic inactivation of Pkd2 results polycystic kidney disease. Cell 1998;93:177-188.
34. Colgin LM, Hackmann AFM, Emond MJ, Monnat RJJ. The unexpected landscape of in vivo somatic mutation in a human epithelial cell lineage. Proc Natl Acad Sci U S A 2002;99:1437-1442.
35. Baert L. Hereditary polycystic kidney disease (adult form): a microdissection study of two cases at an early stage of the disease. Kidney Int 1978;13:519-525.
36. Pirson Y, Lannoy N, Peters D, Geubel A, Gigot JF, Breuning M, et al. Isolated polycystic liver disease as a distinct genetic disease, unlinked to polycystic kidney disease 1 and polycystic kidney disease 2. HEPATOLOGY 1996;23:249-252.
37. Reynolds DM, Falk CT, Li A, King BF, Kamath PS, Huston J 3rd, et al. Identification of a locus for autosomal dominant polycystic liver disease on chromosome 19p 13.2-13.1. Am J Hum Genet 2000;67:1598-1604.
38. Li A, Davila S, Furu L, Qian Q, Tian X, Kamath PS, et al. Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. Am J Hum Genet 2003;72:691-703.
39. Drenth JPH, Morsche RHM, Smink R, Bonifacino JS, Jansen J. Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. Nat Genet 2003;33:345-347.
40. Everson G, Emmett M, Brown W, Redmond P, Thickman D. Functional similarities of hepatic and biliary epithelium: studies of fluid constituents and in vivo secretion in response to secretin. HEPATOLOGY 1990;11:557-565.
41. Weston BS, Malhas AN, Price RG. Structure-function relationships of the extracellular domain of the ADPKD-associated protein, polycystin-1. FEBS Letters 2003;538:8-13.
42. Malhas AN, Abuknesha RA, Price RG. Interaction of the leucine-rich repeats of polycystin-1 with extracellular matrix proteins: possible role in cell proliferation. J Am Soc Nephrol 2002;13:19-26.
43. Ibraghimov-Beskrovnaya O, Bukanov NO, Donohue LC, Dackowski WR, Klinger KW, Landes GM. Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an ADPKD gene, PKD1. Hum Mol Gen 2000;9:1641-1649.
44. Qian F, Germino FJ, Cai Y, Zhang X, Somlo S, Germino GG. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet 1997;16:179-183.
45. Gonzales-Perrett S, Kim K, Ibarra C, Damiano AE, Zotta E, Battelli M, et al. Polycystin-2, the protein mutated in ADPKD, is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci U S A 2001;98:1182-1187.
46. Gonzales-Perrett S, Battelli M, Kim K, Essafi M, Timpanaro G, Moltabetti N, et al. Voltage dependence and pH regulation of human polycystin-2-mediated cation channel activity. J Biol Chem 2002;277:24959-24966.
47. Vassilev PM, Guo L, Chen X, Segal Y, Peng J, Nuria B, et al. Polycystin-2 is a novel cation channel implicated in defective intracellular Ca2+ homeostasis in polycystic kidney disease. Biochem Biophys Res Comm 2001;282:341-350.
48. Koulen P, Cai Y, Geng L, Maeda Y, Nishimura S, Witzgall R, et al. Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol 2002;4:191-197.
49. Cantiello HF. Regulation of calcium signaling by polycystin-2. Am J Physiol 2004;286:F1012-F1029.
50. Huan Y, van Adelsberg J. Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J Clin Invest 1999;104:1459-1468.
51. Peters DJ, van de Wal A, Spruit L, Saris JJ, Breuning MH, Bruijn JA, et al. Cellular localization and tissue distribution of polycystin-1. J Pathol 1999;188:439-446.
52. Wilson PD, Geng L, Li X, Burrow CR. The PKD1 gene product, polycystin-1, is a tyrosine-phosphorylated protein that colocalizes with alpha2, beta1-integrin in focal clusters in adherent renal epithelia. Lab Invest 1999;79:1311-1323.
53. Scheffers MS, van der Bent P, Prins F, Spruit L, Breuning MH, Litvinov SV. et al. Polycystin-1, the product of the polycystic kidney disease 1 gene, colocalizes with desmosomes in MDCK cells. Hum Mol Gen 2000;9:2743-2750.
54. Grimm DH, Cai Y, Chauvet V, Rajendran V, Zeltner R, Geng L, et al. Polycystin-1 distribution is modulated by polycystin-2 expression in mammalian cells. J Biol Chem 2003;278:36786-36793.
55. Cai Y, Maeda Y, Cedzich A, Torres VE, Wu G, Hayashi T, et al. Identification and characterization of polycystin-2, the PKD2 gene product. J Biol Chem 1999;274:28557-28565.
56. Foggensteiner L, Bevan AP, Thomas R, Coleman N, Boulter C, Bradley J, et al. Cellular and subcellular distribution of polycystin-2, the protein product of the PKD2 gene. J Am Soc Nephrol 2000;11:814-827.
57. Newby LJ, Streets AJ, Zhao Y, Harris PC, Ward CJ, Ong AC. Identification, characterization and localization of a novel kidney polycystin-1-polycystin-2 complex. J Biol Chem 2002;277:20763-20773.
58. Pazour GJ, Witman GB. The vertebrate primary cilium is a sensory organelle. Curr Opin Cell Biol 2003;15:105-110.
59. Yoder BK, Hou X, Guay-Woodford LM. The polycystic kidney disease proteins, polycystin-1 and polycystin-2, polaris and cystin are co-localized in renal cilia. J Am Soc Nephrol 2002;13:2508-2516.
60. Masyuk TV, Huang BQ, Ward CJ, Masyuk AI, Yuan D, Splinter PL, et al. Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat. Gastroenterology 2003;125:1303-1310.
61. Praetorius HA, Spring KR. The renal cell primary cilium functions as a flow sensor. Curr Opin Nephrol Hyperten 2003;12:517-520.
62. Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev PM, Li X, et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 2003;33:113-114.
63. Drenth JP, Tahvanainen E, te Morsche RH, Tahvanainen P, Kaarianinen H, Hockerstedt K, et al. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease. HEPATOLOGY 2004;39:924-931.
64. Perrone R, Grubman S, Rogers L, Lee D, Moy E, Murray S, et al. Continuous epithelial cell lines from ADPKD liver cysts exhibit characteristics of intrahepatic biliary epithelium. Am J Physiol 1995;269:G335-G345.
65. Vandenburgh H. Mechanical forces and their second messengers in stimulating cell growth in vitro. Am J Physiol 1992;262:R350-R355.
66. Tanner G, McQuillan P, Maxwell M, Keck J, McAteer J. An in vitro test of the cell stretch-proliferation hypothesis of renal cyst enlargement. J Am Soc Nephrol 1995;6:1230-1241.
67. Obermuller N, Morente N, Kranzlin B, Gretz N, Witzgall R. A possible role for metalloproteases in renal cyst development. Am J Physiol 2001;280:F540-F550.
68. Schaefer L, Han X, Gretz N, Hafner C, Meier K, Matzkies F, et al. Tubular gelatinase A (MMP-2) and its tissue inhibitors in polycystic kidney disease in the Han:SPRD rat. Kidney Int 1996;49:75-81.
69. Murray S, Grubman S, Perrone R, Rojkind M, Moy E, Lee D, et al. Matrix metalloproteinase activity in human intrahepatic biliary epithelial cells from patients with ADPKD. Connect Tiss Res 1996;33:249-256.
70. Bello-Reuss E, Holubec K, Rajaraman S. Angiogenesis in autosomal-dominant polycystic kidney disease. Kidney Int 2001;60:37-45.
71. Munemura C, Uemasu J, Kawasaki H. Epidermal growth factor and endothelin in cyst fluid from autosomal dominant polycystic kidney disease cases: possible evidence of heterogeneity in cystogenesis. Am J Kidney Dis 1994;24:561-568.
72. Gardner KJ, Burnside J, Elzinga L, Locksley R. Cytokines in fluids from polycystic kidneys. Kidney Int 1991;39:718-724.
73. Ye M, Grant M, Sharma M, Elzinga L, Swan S, Torres V, et al. Cyst fluid from human ADPKD promotes cyst formation by renal epithelial cells in vitro. J Am Soc Nephrol 1992;3:984-994.
74. Nichols MT, Gidey E, Matzakos T, Dahl R, Stiegmann G, Shah RJ, et al. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney liver cyst fluid. HEPATOLOGY 2004;40:836-846.
75. Thomas R, McConnel R, Whittacker J, Kirkpatrick P, Bradley J, Sandford R. Identification of mutations in the repeated part of the ADPKD type 1 gene, PKD1, by long-range PCR. Am J Hum Genet 1999;65:39-49.
76. Everson GT, Scherzinger A, Berger-Leff N, Reichen J, Lezotte D, Manco-Johnson M, et al. Polycystic liver disease: quantitation of parenchymal and cyst volumes from computed tomography images and clinical correlates of hepatic cysts. HEPATOLOGY 1988;8:1627-1634.
77. Telenti A, Torres VE, Gross JB, Van Scoy RE, Brown ML, Hattery RR. Hepatic cyst infection in autosomal dominant polycystic kidney disease. Mayo Clin Proc 1990;65:933-942.
78. Uddin W, Ramage JK, Portmann B, Wilson P, Benjamin I, Tan KC, et al. Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment. Gut 1995;36:142-145.
79. Torres VE, Rastogi S, King BF, Stanson AW, Gross JBJ, Nogorney DM. Hepatic venous outflow obstruction in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1994;5:1186-1192.
80. Chapman AB, Rubinstein D, Hughes R, Stears JC, Earnest MP, Johnson AM, et al. Intracranial aneurysms in autosomal dominant polycystic kidney disease. New Engl J Med 1992;327:916-920.
81. Chauveau D, Martinez F, Grunfeld JP. Evaluation of octreotide in massive polycystic liver disease. 12th International Congress of Nephrology Conference Program 1993:487A.
82. van Sonnenberg E, Wroblicka JT, D'Agostino HB, Mathieson JR, Casola G, O'Laoide R, et al. Symptomatic hepatic cysts: percutaneous drainage and sclerosis. Radiology 1994;190:387-392.
83. Tikkakoski T, Makela JT, Leinonen S, Paivansalo M, Merikanto J, Karttunen A, et al. Treatment of symptomatic congenital hepatic cysts with single-session percutaneous drainage and ethanol sclerosis: technique and outcome. J Vase Intervent Radiol 1996;7:235-239.
84. Gigot JF, Jadoul P, Que F, Van Beers BE, Etienne J, Horsmans Y, et al. Adult polycystic liver disease: is fenestration the most adequate operation for long-term management? Ann Surg 1997;225:286-294.
85. Kabbej M, Sauvanet A, Chauveau D, Farges O, Belghiti J. Laparoscopic fenestration in polycystic liver disease. Brit J Surg 1996;83:1697-1701.
86. Gigot JF, Legrand M, Hubens G, de Canniere L, Wibin E, Deweer F, et al. Laparoscopic treatment of nonparasitic liver cysts: adequate selection of patients and surgical technique. World J Surg 1996;20:556-561.
87. Robinson TN, Steigmann GV, Everson GT. Laparoscopic palliation of polycystic liver disease. Surg Endosc, in press.
88. Que F, Nagorney DM, Gross JBJ, Torres VE. Liver resection and cyst fenestration in the treatment of severe polycystic liver disease. Gastroenterology 1995;108:487-494.
89. Klupp J, Bechstein WO, Lobeck H, Neuhaus P. Orthotopic liver transplantation in therapy of advanced polycystic liver disease. Chirurg 1996;67:515-521.
90. Washburn WK, Johnson LB, Lewis WD, Jenkins RL. Liver transplantation for adult polycystic liver disease. Liver Transpl Surg 1996;2:17-22.
91. Lang H, Woellwarth JV, Oldhafer KJ, Behrend M, Schutt HJ, Nashan B, et al. Liver transplantation in patients with polycystic liver disease. Transplant Proc 1997;29:2832-2833.
92. Swenson K, Seu P, Kinkhabwala M, Maggard M, Martin P, Goss J, et al. Liver transplantation for adult polycystic disease. HEPATOLOGY 1998;28:412-415.
93. Pirenne J, Aerts R, Yoong K, Gunson B, Koshiba T, Fourneau I, et al. Liver transplantation for polycystic liver disease. Liver Transpl 2001;7:238-245.
94. Gustafsson BI, Friman S, Mjornstedt L, Olaussen M, Backman L. Liver transplantation for polycystic liver disease - indications and outcomes. Transplant Proc 2003;35:813-814.